Cost analysis of mydriasis strategies in cataract surgery care in the Netherlands

Abstract

published version features the final layout of the paper including the volume, issue and page numbers. Link to publication General rightsCopyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal.If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the "Taverne" license above, please follow below link for the End User

Perioperative time and economic impact of an intracameral combination of mydriatics and anaesthetics in routine cataract surgery

“…By contrast two studies performed in the UK and in The Netherland, respectively showed that the Mydrane regimen had no economic benefit mainly due to increased surgical time and operating room turnaround, and despite reduced preoperative time and nurse cost saving. 13,14 In our study, the duration of surgery performed by surgeons with various experience was not affected by the Mydrane regimen as also reported by Ben Hadj et al 12…”

“…By contrast two studies performed in the UK and in The Netherland, respectively showed that the Mydrane regimen had no economic benefit mainly due to increased surgical time and operating room turnaround, and despite reduced preoperative time and nurse cost saving. 13,14 In our study, the duration of surgery performed by surgeons with various experience was not affected by the Mydrane regimen as also reported by Ben Hadj et al 12 Taken together, all studies recognised that the cost saving using the Mydrane strategy may be dependent on the real-life setting and local organisation, and to the adaptation or improvement of the clinical pathway especially in the setting of high-volume, low-complexity cataract surgery clinics.…”

“…7,13 On the surgeon perspective, the Mydrane strategy provided more satisfaction for IOL implantation, mainly due to less intraoperative miosis. 7,8,14 Finally, mydriatics in Mydrane are less concentrated, and thus systemic safety is improved. 10 In conclusion, this study in real-life showed that Mydrane significantly reduced the pre-operative time and nurse workload, reducing costs in some clinical centres.…”

“…7,13 On the surgeon perspective, the Mydrane strategy provided more satisfaction for IOL implantation, mainly due to less intraoperative miosis. 7,8,14 Finally, mydriatics in Mydrane are less concentrated, and thus systemic safety is improved. 10…”

Pupil diameter during cataract surgery after intracameral injection of the first ready‐to‐use combination of mydriatics and anaesthetic at the beginning of surgery in patients with a preoperative pupil diameter <6 mm

“…The cost‐effectiveness of Mydrane® has been evaluated in two studies (Davey et al, 2018 ; Simons et al, 2021 ). The first, which was conducted in the United Kingdom, indicates that the use of Mydrane®, despite a higher acquisition cost, has a neutral impact on hospital budget.…”